TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.050
0.00 (0.00%)
At close: Sep 14, 2026, 4:00 PM EDT
2.087
+0.037 (1.80%)
Pre-market: Sep 15, 2026, 7:56 AM EDT

TuHURA Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Income
-31.02-28.12-17.21-13.55-9.93
Net Income
-30.63-30.06-22.65-29.32-9.37
Earnings Per Share
-0.54-0.63-1.21-2.47-
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
13.6212.663.6714.25
Total Debt
9.180.70.22.340.14
Net Cash (Debt)
-8.182.9212.451.3214.11
Net Cash Growth
--76.56%843.49%-90.65%-
Net Cash Per Share
-0.150.060.670.11-

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-29.69-27.63-14.73-11.95-7.51
Capital Expenditures
-0.21-0.08-0.06-1.3-0.04
Free Cash Flow
-29.9-27.71-14.79-13.25-7.54
Free Cash Flow Growth
-----

Valuation

Selected indicators aren't available for this stock.